Literature DB >> 10964047

Head and neck in situ carcinoma: incidence, trends, and survival.

B C Reid1, D M Winn, D E Morse, D G Pendrys.   

Abstract

This analysis describes the epidemiology of in situ head and neck carcinomas (anatomic sites of lip, oral cavity, pharynx, larynx) about which there is limited knowledge. Data were derived from nine population-based cancer registries participating in the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program. SEER annual age-adjusted incidence rates for in situ head and neck carcinomas increased from 6.33/1,000,000 person-years (PY) in 1976 to 8.04/1,000,000 PY in 1995 [percent change (PC)=35%, P<0. 001]. From 1976 to 1995 age-adjusted changes in incidence by anatomic site ranged from 53% PC (larynx) to -11% PC (lip) (both P<0. 005). Incidence and survival associated with in situ head and neck carcinomas varied by anatomic site, age, sex, and race and did so in a pattern similar to that seen for invasive carcinomas of this region. However, the climbing incidence of in situ carcinoma, which may be related to increased surveillance, contrasts sharply with the declining incidence of invasive carcinoma.

Entities:  

Mesh:

Year:  2000        PMID: 10964047     DOI: 10.1016/s1368-8375(00)00028-2

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  6 in total

1.  Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis.

Authors:  Alexander Gelbard; Charlie T Garnett; Scott I Abrams; Vyomesh Patel; J Silvio Gutkind; Claudia Palena; Kwong-Yok Tsang; Jeffrey Schlom; James W Hodge
Journal:  Clin Cancer Res       Date:  2006-03-15       Impact factor: 12.531

2.  Dissection of a metastatic gene expression signature into distinct components.

Authors:  Paul Roepman; Erica de Koning; Dik van Leenen; Roel A de Weger; J Alain Kummer; Piet J Slootweg; Frank C P Holstege
Journal:  Genome Biol       Date:  2006       Impact factor: 13.583

3.  In Vitro Study of Synergic Effect of Cisplatin and Low Molecular Weight Heparin on Oral Squamous Cell Carcinoma.

Authors:  Fabio Camacho-Alonso; T Gómez-Albentosa; R E Oñate-Sánchez; M R Tudela-Mulero; M Sánchez-Siles; Francisco J Gómez-García; Yolanda Guerrero-Sánchez
Journal:  Front Oncol       Date:  2020-11-18       Impact factor: 6.244

4.  Porphyromonas gingivalis W83 Membrane Components Induce Distinct Profiles of Metabolic Genes in Oral Squamous Carcinoma Cells.

Authors:  Sabine Groeger; Jens Martin Herrmann; Trinad Chakraborty; Eugen Domann; Sabine Ruf; Joerg Meyle
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

5.  Recombinant Porphyromonas gingivalis W83 FimA alters immune response and metabolic gene expression in oral squamous carcinoma cells.

Authors:  Sabine E Groeger; Martina Hudel; Silke Zechel-Gran; Jens M Herrmann; Trinad Chakraborty; Eugen Domann; Joerg Meyle
Journal:  Clin Exp Dent Res       Date:  2022-05-15

6.  ASC contributes to metastasis of oral cavity squamous cell carcinoma.

Authors:  Chi-Sheng Wu; Kai-Ping Chang; Chun-Nan OuYang; Huang-Kai Kao; Chuen Hsueh; Lih-Chyang Chen; Hsiao-Yun Cheng; Ying Liang; Willisa Liou; Chih-Lung Liang; Yu-Sun Chang
Journal:  Oncotarget       Date:  2016-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.